Afinion HbA1c Dx— 510(k) K180296
Substantially EquivalentAlere Technologies AS
FDA 510(k) clearance K180296 for Afinion HbA1c Dx, Substantially Equivalent on 2018-05-07. Applicant: Alere Technologies AS. Device class: 2.
Clearance details
- Applicant
- Alere Technologies AS
- Product code
- Code PDJ
- Device class
- Class 2
- Regulation
- 21 CFR 862.1373
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Traditional
- Location
- Oslo, NO
Recent devices under product code PDJ
view allMore clearances from Alere Technologies AS
view allRecalls naming K180296
K-number listed on FDA's recall recordMatched by K-number from FDA's Recall Enterprise System record (openFDA device/recallk_numbers) — these recalls explicitly list K180296.
Data sourced from openFDA. This site is unofficial and independent of the FDA.